These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27546845)

  • 1. Neuroendocrine Tumors.
    Basuroy R; Srirajaskanthan R; Ramage JK
    Gastroenterol Clin North Am; 2016 Sep; 45(3):487-507. PubMed ID: 27546845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroendocrine tumors of the gastrointestinal tract].
    Arnold C
    Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathological implications in the neuroendocrine gastrointestinal system].
    Piette C; Polus M; Louis E
    Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
    J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.
    Cloyd JM; Poultsides GA
    World J Gastroenterol; 2015 Aug; 21(32):9512-25. PubMed ID: 26327759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pancreatic neuroendocrine tumors.
    Dickson PV; Behrman SW
    Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract.
    Pelley RJ; Bukowski RM
    Curr Opin Oncol; 1997 Jan; 9(1):68-74. PubMed ID: 9090496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasized pancreatic neuroendocrine tumor in a teenage girl: a case report.
    Tremmel T; Holland-Cunz S; Günther P
    J Med Case Rep; 2015 Oct; 9():230. PubMed ID: 26438383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver Metastases.
    Iwasaki M; Tsuchida K; Jinnai H; Komatsubara T; Arisaka T; Tsunemi M; Nakano M; Iijima M; Hiraishi H
    Intern Med; 2017; 56(5):517-522. PubMed ID: 28250297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
    Pauwels S; Leners N; Fiasse R; Jamar F
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):15-20. PubMed ID: 7992075
    [No Abstract]   [Full Text] [Related]  

  • 11. Principles of diagnosis and management of neuroendocrine tumours.
    Raphael MJ; Chan DL; Law C; Singh S
    CMAJ; 2017 Mar; 189(10):E398-E404. PubMed ID: 28385820
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic-directed Therapies in Patients with Neuroendocrine Tumors.
    Kennedy AS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):193-207. PubMed ID: 26614377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
    Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
    Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete remission of inoperable hepatic and bone metastases due to neuroendocrine pancreatic tumour 3 years after peptide receptor radionucleotide therapy.
    Soeiro P; Martins H; Silva R; Moreira AP
    BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32234855
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.
    Cives M; Strosberg J
    Curr Treat Options Oncol; 2017 Mar; 18(3):14. PubMed ID: 28286921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of metastatic endocrine tumors of the gastrointestinal tract with octreotide and interferon-alpha].
    Nold R; Frank M; Kajdan U; Trost U; Klose KJ; Arnold R
    Z Gastroenterol; 1994 Apr; 32(4):193-7. PubMed ID: 7517086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
    Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
    Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of neuroendocrine tumors.
    Kulke M
    Curr Treat Options Oncol; 2005 Sep; 6(5):397-409. PubMed ID: 16107243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroendocrine tumours of pancreas and gastrointestinal tract].
    Tsimmerman IaS
    Klin Med (Mosk); 2009; 87(12):7-13. PubMed ID: 20135878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.